Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-11-22T05:01:59.588Z Has data issue: false hasContentIssue false
  • English
  • Français

Candida tropicalis

Published online by Cambridge University Press:  21 June 2016

Get access Rights & Permissions [Opens in a new window]

Extract

Candidiasis is a well-recognized complication of immunosuppression, parenteral nutrition, surgery and broad spectrum antimicrobial chemotherapy. The majority of cases of candidiasis are caused by Candida albicans. Since the mid-1970's, however, Candida tropicalis has assumed an increasingly important pathogenic role, especially in granulocytopenic patients.

C tropicalis is a unicellar yeast organism that belongs to the genus Candida, the family Cryptococcaceae and the group Deuteromycetes (Fungi Imperfecti). C tropicalis grows well at 25°C and 37°C on blood and Sabouraud agars in an aerobic atmosphere, producing white, smooth colonies (Figure 1). It forms pellicle in broth. Microscopic examination shows round, oval or oblong noncapsulated budding cells (blasto-conidia), 2.5 μm X 3-14 μm in size. Singe cells, clusters or chains may be seen. C tropicalis forms hyphae and pseudohyphae, but not the germ tubes, unlike C albicans. (C tropicalis strains forming morphologically atypical germ tubes have been repotted, but are rare.) N 0 chlamydospores are produced on cornmeal agar. C tropicalis assimilates glucose, maltose, sucrose, galactose, cellobiose, xylose and trehalose, and ferments glucose, maltose, sucrose, galactose and trehalose. (Sucrose-negative variants have been described.”) Several commercially available biochemical panels are widely used for identifying C tropicalis.

Type
Special Sections
Information
Infection Control & Hospital Epidemiology , Volume 10 , Issue 6 , June 1989 , pp. 280 - 283
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1989

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Gregory, DW: Candidiasis. Infect Control 1983; 4: 164–166.Google Scholar
2. Wingard, JR, Merz, WG, Saral, R: Candido tropicalis; A major pathogen in immunocompromised patients. Ann Intern Med 1979; 91: 539–543.Google Scholar
3. Horn, R, Wong, B, Kiehn, TE. et al: Fungemia in a cancer hospital: Changing frequency, earlier onset, and results of therapy. Rev Infect Dis 1985; 7: 646–655.Google Scholar
4. Cooper, BH, Silva-Hutner, M: Yeasts ot medical importance, in Lennette, EH, Balows, A, Hausler, WJ. et al (eds): Manual of Chinical Microbiology, ed 1, Washington, DC, American Society tor Microbiology, 1985. pp 526–541.Google Scholar
5. Tierno, PM, Milstoc, M: Germ tube-positive Candida tropicalis . Am J Clin Pathol 1977; 68: 294–295.Google Scholar
6. Ahearn, DG, Lawrence, JB: Disseminated candidiasis caused by a suerose-negative variant of Candida tropicalis . J Clin Microbiol 1984; 20: 187–190.Google Scholar
7. Richart, R, Dammin, GJ: Candida tropicalis as a pathogen for man. N Engl I Med 1960; 263: 474–477.Google Scholar
8. Soll, DR, Staebell, M, Langtimm, C. el al: Multiple Candida strains in the course of a single systemic infection. J Clin Miciobiol 1988; 26: 1448–1459.Google Scholar
9. Goetz, MF, Taylor, DON: A naturally occurring outbreak of Candida tiopicalis infection in a laboratory mouse colony. Am J Pathol 1907; 50: 361–369.Google Scholar
10. Wingard, JR, Dick, JD, Mery, WG. et al: Differences in virulence of clinical isolates of Candida tropicalis and Candida albicans in mice. Infect Immun 1982: 37: 833–836.Google Scholar
11. Walsh, TJ, Merz, WG: Pathologic features in the human alimentary tract associated with invasiveness of Candida tropicalis . Am J Clin Pathol 1986; 85: 498–502.Google Scholar
12. Fromtling, RA. Abruzzo, GK, Giltinan, DM: Candida tropicalis infection in normal, diabetic, and neutropenic mice. J Clin Microbiol 1987; 25: 1416–1420.Google Scholar
13. Rotrosen, D, Calderone, RA, Edwards, JF: Adherence of Candida species to host tissues and plastic surfaces. Rev Infect Dis 1980; 8: 73–85.Google Scholar
14. Rotrosen, D, Gibson, TR, Edwards, JF: Adherence of Candida species to intravenous catheters. J Infect Dis 1983; 147:594.CrossRefGoogle ScholarPubMed
15. Louria, DB. Stiff, DP, Bennett, B: Disseminated moniliasis in the adult. Medicine 1962; 41: 307–337.Google Scholar
16. Horowitz, Bj, Stanley, WE, Lippman, L: Candida tropicalis vulvovaginitis. Obstet Gynecol 1985: 60: 229–232.Google Scholar
17. Chadwick, DW, Hartley, E, Mackinnon, DM: Meningitis caused by Candida tropicalis . Arch Neurol 1980; 27: 175–176.CrossRefGoogle Scholar
18. Murray, HW, Fialk, MA, Roberts, RB: Candida arthritis. Am J Med 1976; 60: 587–595.CrossRefGoogle ScholarPubMed
19. Wall, BA. Wemblatt, ME. Darnall, JT, et al: Candida tropicalis arthritis and bursitis. JAMA 1982; 248: 1098–1099.Google Scholar
20. Eug, RHK, Sen, P. Browne, K. et al: Candida pericarditis. Am J Med 1981; 70: 867–869.Google Scholar
21. Weingart, JS, Writz, DC Irwing, NW: Monila osteomyelitis: Report of case resulting from thrush. Am J Clin Pathol 1942; 8:597–600.Google Scholar
22. Conn, NK. Crean, GP. Maccabe, AF et al: Systemic candidiasis and endocarditis due to C tropicalis . Br Med J 1959; 1:944–947.Google Scholar
23. Wheeler, JG, Boyle, R, Abramson, J: Candida tropicalis pyelonephritis successfully treated with 5-fluoytocytosine and surgery. J Pediatr 1983; 102:627–629.10.1016/S0022-3476(83)80208-XGoogle Scholar
24. Graybill, JR, Galgiani, JN, Jorgensen, JH, et al: Ketoconazole therapy for fungal urinary tract infectious. J Urol 1983; 129:68–70.CrossRefGoogle Scholar
25. Seidenfeld, SM, Lemaistre, CF. Setiawan, H. et al: Emphysematous pyelonephritis caused by Candida tropicalis . J Infect Dis 1982: 140:569.CrossRefGoogle Scholar
26. Torres-Rojas, JR. Stratton, CW. Sanders, CV, et al: Candidal suppurative peripheral thromhophlehilis. Ann Intern Med 1982; 90:431–435.Google Scholar
27. Arena, FP. Perlin, M. Brahuman, H: Fever, rash, and myalgias of disseminated candidiasis during antifungal therapy. Arch Intern Med 1981; 141:1233.CrossRefGoogle Scholar
28. Bodey, GP. Luna, M: Skin lesions associated with disseminated candidiasis. JAMA 1974; 229:1166–1468.CrossRefGoogle ScholarPubMed
29. Jarowski, CI. Fialk, MA. Murray, HW, et al: Fever, rash and muscle tenderness: A distinctive clinical presentation of disseminated candidiasis. Arch Intern Med 1978: 138:544–546.CrossRefGoogle ScholarPubMed
30. Kressel, B, Szewezyk, C, Tuazon, CU: Early clinical recognition of disseminated candidiasis by muscle and skin biopsy. Arch Intern Med 1978; 138:429–433.Google Scholar
31. Thaler, M. Pastakia, B. Shawker, TH. et al: Hepatic candidiasis in cancer patients: The evolving picture of the syndrome. Ann Intern Med 1988; 108:88–100.Google Scholar
32. Young, RC. Bennett, JE. Geelhoed, GW, et al: Fungemia with compromised host resistance. Ann Intern Med 1974; 80:605–612.CrossRefGoogle ScholarPubMed
33. Kobayashi, C: Fulminant pneumonia and death in an immunocompromised woman. Am J Med 1983; 75: 1043–1052.Google Scholar
34. Sandford, GR, Merz, WG, Wingard, JR. et al; The value of fungal surveillance cultures as predictors of systemic fungal infections. J Infect Dis 1980; 142:503–509.Google Scholar
35. Pfaller, M. Cabezudo, I, Koontz, F et al: Predictive value of surveillance cultures tor systemic infection due to Candida species. Eur J Clin Microbiol Infect Dis 1987:6:628–633.Google Scholar
36. Gray, LD. Roberts, GD: Laboratory diagnosis of systemic fungal infections, in Drulz, DJ (ed): Systemic fungal infections: Diagnosis and treatment I. Infect Dis Clin North Am 1988; 2:779–803.Google Scholar
37. Woods, RA. Bard, M, Jackson, IE. et al: Resistance to polyene antibiotics and correlated sterol changes in two isolates of Candida tropicalis from a patient with an amphotericin B-resistant funguria. J Infect Dis 1974; 129:53–58.10.1093/infdis/129.1.53Google Scholar
38. Drutz, DJ. Lehrer, RI: Development of amphoteric in B-resistant Candida tropicalis in a patient with detective lenkocyte function. Am J Med Sci 1978; 276:77–92.Google Scholar
39. Merz, WG. Sandford, GR: Isolation and characterization of a polyene-resistant variant of Candida tropicalis . J Clin Microbiol 1979: 9:677–680.CrossRefGoogle ScholarPubMed
40. Dick, JD. Merz, WG, Saral, R: Incidence ol polyene-resistant yeasts recovered from clinical specimens. Antimicrob Agents Chemother 1980; 18:158–163.CrossRefGoogle Scholar
41. Powderly, WG. Kobayashi, GS. Herzig, GP, et al: Amphotericin B-resistant yeast infection in severely immunocompromised patients. Am J Med 1988: 81:826–832.Google Scholar
42. Thaler, M. Bacher, J. O'Leary, T. et al: Evaluation of single drug and combination antifungal therapy in an experimental model of candidiasis in rabbits with prolonged neutropenia. J Infect Dis 1988; 158:80–88.Google Scholar
43. Graybill, JR: Therapeutic agents, in Drutz, DJ (eds); Systemic fungal infections: Diagnosis and treatment I. Infect Dis Clin North Am 1988; 2:805–825.Google Scholar
44. Fainstein, V. Bodey, GP, Elting, L, et al: Amphotericin B or ketoconazole therapy of fungal infections in neutropenic cancer patients. Antimicrob Agents Chemother 1987; 31:11–15.Google Scholar
45. Stevens, DA: The new generation of antifungal drugs. Eur J clin Microbiol Infect Dis 1988: 7:732–735.CrossRefGoogle ScholarPubMed
46. Hall, GS. Myles, G. Pratt, KJ. et al: Gilofungin (LY121019). an antifungal agent with specific: activity against Candida albicans and Candida tropicalis . Antimicroh Agents Chemother 1988; 32:1331–1335.CrossRefGoogle ScholarPubMed